The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades right before signs or symptoms emerge. Whilst these technological advances stand for impressive progress in understanding neurodegenerative health conditions, https://helens754ufq5.wikibestproducts.com/user